Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2001-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Brimonidine Tartrate; Timolol

Criteria

Inclusion Criteria:

• Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes

• Patient requires IOP-lowering drug in both eyes

Exclusion Criteria:

• Uncontrolled medical conditions

• contraindication to beta-adrenoceptor antagonist or brimonidine therapy